DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/15169
Title: Current trends in treatment of obesity in Karachi and possibilities of cost minimization
Authors: Hussain, Mirza Izhar
Naqvi, Baqir Shyum
Keywords: Cost minimization
overweight
obesity
evidence-based therapeutic guidelines
compelling indications
Issue Date: 18-Mar-2015
Publisher: Karachi: Faculty of Pharmacy & Pharmaceutical Sciences University of Karachi
Citation: Hussain, M. I., & Naqvi, B. S. (2015). Current trends in treatment of obesity in Karachi and possibilities of cost minimization. Pak J Pharm Sci, 28(2 Suppl), 765-72.
Abstract: Our study finds out drug usage trends in over weight and obese patients without any compelling indications in Karachi, looks for deviations of current practices from evidence based antihypertensive therapeutic guidelines and identifies not only cost minimization opportunities but also communication strategies to improve patients’ awareness and compliance to achieve therapeutic goal. In present study two sets were used. Randomized stratified independent surveys were conducted in hospital doctors and family physicians (general ractitioners), using pretested questionnaires. Sample size was 100. Statistical analysis was conducted on Statistical Package for Social Science (SPSS). Opportunities of cost minimization were also analyzed. One the basis of doctors’ feedback, preference is given to non-pharmacologic management of obesity. Mass media campaign and media usage were recommended to increase patients awareness and patients’ education along with strengthening family support systems was recommended for better compliance of the patients to doctor’s advice. Local therapeutic guidelines for weight reduction were not found. Feedbacks showed that global therapeutic guidelines were followed by the doctors practicing in the community and hospitals in Karachi. However, high price branded drugs were used instead of low priced generic therapeutic equivalents. Patient’s education is required for better awareness and improving patients’ compliance. The doctors found preferring brand leaders instead of low cost options. This trend increases cost of therapy by 0.59 to 4.17 times. Therefore, there are great opportunities for cost minimization by using evidence-based clinically effective and safe medicines.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/15169
ISSN: 1011-601X
Appears in Collections:2006,Part-1

Files in This Item:
File Description SizeFormat 
18-SUP-220.htm147 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.